COYA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Coya Therapeutics Inc (COYA) is not a strong buy for a beginner investor with a long-term focus at this time. While the company has shown significant revenue growth and improved financial metrics, the technical indicators and trading trends do not support a clear upward momentum. Additionally, the lack of recent news, congress trading data, or strong proprietary trading signals further weakens the case for immediate investment.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is in the neutral zone, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting the stock is still in a downtrend. Key resistance levels are at 4.45 and 4.655, with support at 3.785 and 3.58.
Significant revenue growth in 2025/Q4, up 202768.80% YoY. Improved net income and EPS metrics, showing progress toward profitability.
suggests uncertainty.
In 2025/Q4, revenue increased to $3,959,999 (up 202768.80% YoY), net income improved to -$5,708,542 (up 95.78% YoY), and EPS increased to -0.34 (up 88.89% YoY). Gross margin remained at 100%.
No analyst rating or price target data available.
